223 related articles for article (PubMed ID: 37852260)
21. The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses.
Peng Q; Li K; Sacks SH; Zhou W
Inflamm Allergy Drug Targets; 2009 Jul; 8(3):236-46. PubMed ID: 19601884
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of activation and biased signaling in complement receptor C5aR1.
Feng Y; Zhao C; Deng Y; Wang H; Ma L; Liu S; Tian X; Wang B; Bin Y; Chen P; Yan W; Fu P; Shao Z
Cell Res; 2023 Apr; 33(4):312-324. PubMed ID: 36806352
[TBL] [Abstract][Full Text] [Related]
23. Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg.
Bajic G; Yatime L; Klos A; Andersen GR
Protein Sci; 2013 Feb; 22(2):204-12. PubMed ID: 23184394
[TBL] [Abstract][Full Text] [Related]
24. C3aR and C5aR1 act as key regulators of human and mouse β-cell function.
Atanes P; Ruz-Maldonado I; Pingitore A; Hawkes R; Liu B; Zhao M; Huang GC; Persaud SJ; Amisten S
Cell Mol Life Sci; 2018 Feb; 75(4):715-726. PubMed ID: 28921001
[TBL] [Abstract][Full Text] [Related]
25. Neutraligands of C5a can potentially occlude the interaction of C5a with the complement receptors C5aR1 and C5aR2.
Das A; Ghosh M; Gupta PK; Rana S
J Cell Biochem; 2023 Feb; 124(2):266-281. PubMed ID: 36565188
[TBL] [Abstract][Full Text] [Related]
26. Complement anaphylatoxin receptors on neurons: new tricks for old receptors?
Nataf S; Stahel PF; Davoust N; Barnum SR
Trends Neurosci; 1999 Sep; 22(9):397-402. PubMed ID: 10441300
[TBL] [Abstract][Full Text] [Related]
27. Expression of a functional anaphylatoxin C3a receptor by astrocytes.
Ischenko A; Sayah S; Patte C; Andreev S; Gasque P; Schouft MT; Vaudry H; Fontaine M
J Neurochem; 1998 Dec; 71(6):2487-96. PubMed ID: 9832147
[TBL] [Abstract][Full Text] [Related]
28. Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis.
Sauter RJ; Sauter M; Reis ES; Emschermann FN; Nording H; Ebenhöch S; Kraft P; Münzer P; Mauler M; Rheinlaender J; Madlung J; Edlich F; Schäffer TE; Meuth SG; Duerschmied D; Geisler T; Borst O; Gawaz M; Kleinschnitz C; Lambris JD; Langer HF
Circulation; 2018 Oct; 138(16):1720-1735. PubMed ID: 29802205
[TBL] [Abstract][Full Text] [Related]
29. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
[TBL] [Abstract][Full Text] [Related]
30. The "C3aR Antagonist" SB290157 is a Partial C5aR2 Agonist.
Li XX; Kumar V; Clark RJ; Lee JD; Woodruff TM
Front Pharmacol; 2020; 11():591398. PubMed ID: 33551801
[TBL] [Abstract][Full Text] [Related]
31. The Complement Anaphylatoxins C5a and C3a Suppress IFN-β Production in Response to
Mueller-Ortiz SL; Calame DG; Shenoi N; Li YD; Wetsel RA
J Immunol; 2017 Apr; 198(8):3237-3244. PubMed ID: 28275134
[No Abstract] [Full Text] [Related]
32. Immune cell-derived C3a and C5a costimulate human T cell alloimmunity.
Cravedi P; Leventhal J; Lakhani P; Ward SC; Donovan MJ; Heeger PS
Am J Transplant; 2013 Oct; 13(10):2530-9. PubMed ID: 24033923
[TBL] [Abstract][Full Text] [Related]
33. The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics.
Ghosh M; Rana S
Int Immunopharmacol; 2023 May; 118():110081. PubMed ID: 36989901
[TBL] [Abstract][Full Text] [Related]
34. Anaphylatoxins and their corresponding receptors as potential drivers in cartilage calcification during osteoarthritis progression.
Ruths L; Huber-Lang M; Schulze-Tanzil G; Riegger J
Osteoarthritis Cartilage; 2024 May; 32(5):514-525. PubMed ID: 38242312
[TBL] [Abstract][Full Text] [Related]
35. Role of complement anaphylatoxin receptors (C3aR, C5aR) in the development of the rat cerebellum.
Bénard M; Raoult E; Vaudry D; Leprince J; Falluel-Morel A; Gonzalez BJ; Galas L; Vaudry H; Fontaine M
Mol Immunol; 2008 Aug; 45(14):3767-74. PubMed ID: 18635264
[TBL] [Abstract][Full Text] [Related]
36. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression.
Sayah S; Ischenko AM; Zhakhov A; Bonnard AS; Fontaine M
J Neurochem; 1999 Jun; 72(6):2426-36. PubMed ID: 10349852
[TBL] [Abstract][Full Text] [Related]
37. Emerging Insights into the Structure and Function of Complement C5a Receptors.
Pandey S; Maharana J; Li XX; Woodruff TM; Shukla AK
Trends Biochem Sci; 2020 Aug; 45(8):693-705. PubMed ID: 32402749
[TBL] [Abstract][Full Text] [Related]
38. Chronic myelogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a.
Kretzschmar T; Jeromin A; Gietz C; Bautsch W; Klos A; Köhl J; Rechkemmer G; Bitter-Suermann D
Eur J Immunol; 1993 Feb; 23(2):558-61. PubMed ID: 7679650
[TBL] [Abstract][Full Text] [Related]
39. Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1.
Pandey S; Li XX; Srivastava A; Baidya M; Kumari P; Dwivedi H; Chaturvedi M; Ghosh E; Woodruff TM; Shukla AK
J Biol Chem; 2019 Jun; 294(24):9416-9429. PubMed ID: 31036565
[TBL] [Abstract][Full Text] [Related]
40. Complement C3a enhances CXCL12 (SDF-1)-mediated chemotaxis of bone marrow hematopoietic cells independently of C3a receptor.
Honczarenko M; Ratajczak MZ; Nicholson-Weller A; Silberstein LE
J Immunol; 2005 Sep; 175(6):3698-706. PubMed ID: 16148115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
